pyrrolidonecarboxylic acid has been researched along with Angiogenesis, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gacs, A; Hegedüs, R; Kapuvári, B; Manea, M; Mező, G; Schulcz, Á; Tóvári, J; Vincze, B | 1 |
Baba, K; Kido, T; Kimura, Y; Sumiyoshi, M; Takaku, T | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and Angiogenesis, Pathologic
Article | Year |
---|---|
Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice.
Topics: Animals; Antibiotics, Antineoplastic; Butyric Acid; Cell Proliferation; Colorectal Neoplasms; Daunorubicin; Female; Gonadotropin-Releasing Hormone; Heart; HT29 Cells; Humans; Liver; Male; Mice; Neovascularization, Pathologic; Pyrrolidonecarboxylic Acid; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions.
Topics: Administration, Oral; Agaricus; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; CD8-Positive T-Lymphocytes; Collagen; Drug Combinations; Female; Killer Cells, Natural; Laminin; Lung Neoplasms; Lymphocyte Count; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Proteoglycans; Pyrrolidonecarboxylic Acid; Spleen; Vascular Endothelial Growth Factor A | 2004 |